Clinical Trial: A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study of Restylane Skinboosters Vital Lidocaine

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07047638) titled 'A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study of Restylane Skinboosters Vital Lidocaine' on June 24.

Brief Summary: This is a randomized, evaluator-blinded, no-treatment controlled, study to evaluate the effectiveness and safety of Restylane Skinboosters Vital Lidocaine treatment to improve skin quality of the face in China. Subjects of Chinese origin, age 18 years, who are eligible for treatment to improve skin quality of the face. Study center is up to 8.

A total of approximately 171 subjects will be randomized (2:1) to either treatment with Restylane Skinboosters Vital Lidocaine Treatment Group (appr...